Announcements Trials
Browse Landscape

Status

Completed 5Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Breast 1

Conditions

Ovarian Neoplasms 368Uterine Cervical Neoplasms 144Carcinoma, Ovarian Epithelial 108Fallopian Tube Neoplasms 105Endometrial Neoplasms 99Breast Neoplasms 82Carcinoma, Non-Small-Cell Lung 70Neoplasms 55Stomach Neoplasms 49Melanoma 44Colorectal Neoplasms 44Neoplasm Metastasis 40Pancreatic Neoplasms 37Carcinoma, Renal Cell 36Triple Negative Breast Neoplasms 33Recurrence 31Squamous Cell Carcinoma of Head and Neck 28Lung Neoplasms 28Uterine Neoplasms 25Sarcoma 25Urinary Bladder Neoplasms 24Peritoneal Neoplasms 24Uterine Cervical Dysplasia 23Prostatic Neoplasms 23Colonic Neoplasms 23Esophageal Neoplasms 22Head and Neck Neoplasms 21Carcinoma, Transitional Cell 18Testicular Neoplasms 16Small Cell Lung Carcinoma 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hypersensitivity × Gynecologic × Clear all
NCT00288275 2012-10-05

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Precision Therapeutics

Terminated
256 enrolled
Gynecologic

Fallopian Tube Neoplasms, Hypersensitivity, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT00669422 2012-10-05

ChemoFx® PRO - A Post-Market Data Collection Study

Precision Therapeutics

Terminated
2,756 enrolled
Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Hypersensitivity, Ovarian Neoplasms, Recurrence, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡